"Lorista": imiyalelo ukusetyenziswa, ixabiso, kunye nohlaziyo. Togu cheap "Loristy"

Ngenjongo ukuya ukwandiswa ebalulekileyo kubomi babantu ziingcali WHO ukuphuhlisa amalinge ukuba ulwe nesifo sentliziyo. Le ezimbi kakhulu rhoqo kuluhlu lwabo uthathwa lwegazi. Iba ityala ngokoyiswa iindonga imithambo yegazi wonke umzimba. Oku kakhulu yondele kwi ingqondo, intliziyo, izintso kunye retina. Ngenxa lwegazi ebangela kwezifo, owandisa ngqo izinga lokusweleka yabemi. Kwakhona, ngenxa eliphezulu kwegazi kunciphisa umgangatho wobomi izigulane '.

Ngenxa kweli hlabathi, kweminyaka yokuphila nezinga ibaluleke ngokwenene, imfuneko yokulawula lwegazi, uphambuke ezintethweni ukwanda ngamandla rhoqo ingcinezelo. Oku kwenziwa ngokusebenzisa kwiiklasi ezininzi iziyobisi: ACE inhibitors, blocker of receptors zayo, calcium abamelene blocker kunye womchamo. Ezi zinto zenza isiseko unyango lwegazi. Kwaye ichiza "Lorista" analogue nawethutyana, kwakunye nezo zecandelo le into esebenzayo kuhlala kakuhle, iziyobisi iindleko-olusebenzayo ethandwayo.

iimpawu Jikelele ichiza

"Lorista" substitutes lweziyobisi zimelwe eklasini lwamachiza umfutho ngokubanzi, iqulathe losartan. Le into isiyobisi i angiotensin receptor blocker Uhlobo lwesibini. ukusebenza kwayo therapeutic ke inhibition le nomphetho owujikelezileyo receptor angiotensin kunye isitya endothelial ukuba ucinga nzulu akunakwenzeka yokunciphisa isitya. uxinzelelo lwegazi siyongezwa kwaye uhlala kwinqanaba lokuqala. Iveliswe neziyobisi inkampani Slovenian KRKA.

Kuyaphawuleka ukuba "Lorista" - oko generic, kwaye losartan original 'Cozaar'. Kodwa eli chiza umgangatho ophezulu, ngoko njani na inkampani usikhathalele umfanekiso wayo omhle. Oku kungqina bioequivalence isifundo sethu 'Cozaar' yaye 'Loristy ", nto leyo engqina impumelelo yokugqibela endaweni yayo elichanekileyo.

Imiyalelo yokusebenzisa

Okuqhotyoshelwe ichiza "Lorista" umyalelo, angqina nomonde kunye neengcali, ngokunjalo iimvavanyo isicelo onyango zingqina ukusebenza beziyobisi unyango lwegazi. Kwaye ngokwemvelo, ukuba unyango eziphumeleleyo kunokwenzeka ngokuhambelana nezindululo ezibekwe imiyalelo ukusetyenziswa. Phakathi amalungiselelo alo, ezi ngongoma zilandelayo:

• spectrum kwakuthethwa;

• umthamo iirejimeni kunye nokukhetha idosi;

• iimpawu reception;

• Izimo;

• izinyathelo.

Kuba nganye amagatya imiyalelo ukusetyenziswa, bona ngezantsi.

ubungqina

Zonke ukufundwa kufuneka eziphicothwe imiyalelo ehamba, apho kuvela uluhlu. Injongo yale ncwadana kukuba ukwahlula le window zonyango ichiza. Ngoko ke, i "Lorista" isetyenziselwa unyango nomfutho nisaqala ubume ngexesha kuphuhliso monotherapy kunye ukhohlokhohlo owomileyo njengempendulo ekufumaneni amachiza ukusuka kwiqela ACE inhibitor. Le yokugqibela ziyasebenza ngakumbi, lo gama "Losartan" - indawo uphuhliso ziziphumo ebezingalindelekanga ekusetyenzisweni kwabo.

Enye siboniso unyango lwe lwegazi, izidanga aphezulu yonyango indibaniselwano kwizigulane kunye emngciphekweni omkhulu sentliziyo. Apha, isicelo sayo kwakhona amathuba eliqingqiweyo iziphumo ezibi ACE inhibitors. Ukuba akukho iziphumo ebezingalindelekanga, asikuko ukusetyenziswa kakuhle kwe "Losartan" kunye nezinye blocker receptor angiotensin kunye inhibitors ze enzyme.

"Lorista" Libonisa ukuba unyango lwe ukusilela intliziyo kwezinye izigulane abasindileyo nesiphumo esiphawulweyo kuniko umfutho yonyango ye-enzyme inhibitors. Kwakhona, ubukho seswekile sinwenwa "Losartan", ixabiso iphantsi ngokwaneleyo, eli chiza oyikhethileyo. Nangona kunjalo, oku ukunyamezelana ukuba inhibitors ACE, leyo ithe amandla kunye nokuqalisa kwe-umfutho ngesantya.

umthamo rejimeni kwaye nokukhetha idosi

Nayiphi Togu "Loristy" kukhethiwe ngqongqo ngabanye. Kananjalo akanakuba kukho nje ubudlelwane obucacileyo phakathi iqondo lwegazi kunye umthamo ichiza. Ngamana kubakho ezinye iindlela ezinxulumene ubungqongqo sifo engundoqo kuphela. Xa lwegazi, lo isidanga sokuqala lomngcipheko sele omkhulu sentliziyo unganika 12.5 okanye 25 mg "Loristy" ngosuku. Ngenxa yokwanda iqondo lwegazi siyakhula futhi balawule.

Ixabiso "Losartan" ukulungiselela - le nto mncinane ekukhetheni igama elithile lorhwebo. oyidlayo kuphela Soloko ebalulekileyo. Kwaye unako ukufikelela ukuya ku-200 mg ngosuku yahlulwe amathamo amabini. Le kwingongoma nganye impumelelo unyango - a amanqanaba uxinzelelo lwegazi ngokwanelisayo. Xa uxinzelelo lwegazi iSystolic ngexesha unyango lingaphumi ngentla 140, ithamo elinikiweyo beziyobisi ezaneleyo ukuze unyango.

Kwimeko CHF kunye nokungabikho lwegazi ukuqeshwa inhibitors ACE okanye ARBs kuyimfuneko ngenjongo yokuba ingcinezelo kweenkqubo abanesigulo engabalulekanga. Kulo mzekelo, ichiza eyabelwe ubuninzi zivunwe ithamo. Oku titrated ngokuxhomekeke kwinqanaba ingcinezelo, ngoko angawi ngezantsi 110.

imiphumela emibi

Drug "Lorista" ukusebenza ngomhla iindlela ngokobugcisa yommiselo koxinzelelo, yaye ngenxa yoko ezinye iziphumo ebezingalindelekanga. Abanye babo kananjalo neziphumo yityhefu ophezu kwesibindi, inkqubo hematopoietic. Eyona eqhelekileyo, oko kukuthi, ezichaphazela malunga 1.7% yezigulane, iziphumo ebezingalindelekanga ziquka: iintlungu esiswini eliphezulu, lidiniwe ubuthathaka, uphuhliso ubuso kunye yesiqephu nokudumba. Ukulinganisa, ukuba isehlo impendulo placebo correlates kunye nezihlandlo ezi ziphumo bezingalindelekanga, ngenxa apho ekulungiseleleni uthathwa ikhuseleke phantsi kwemiqathango ethile.

"Lorista" ezinqabileyo, okt 1% amatyala, ukuba iyangongoza intliziyo. 2% kwe izigulane bakholisa ukukhalaza kuphuhliso urhudo emva ezithatha ichiza, "Losartan". Ixabiso kokuma ezinjalo iphantsi kakhulu, ngenxa yokuba inani ezinjalo engephi. Hi ndlela leyi, nokuba ngaphandle kokusebenzisa iyeza, kodwa kuphela ngenxa urhudo placebo kunye ukuqunjelwa eziqulunqwe 1.9% kwizigulane.

Ayifane, izigulane ubuncinane 1 100 waqaphela ukubonakala intlungu izihlunu, iqolo, ukuphuhliswa amahlaba kwezihlunu. Le status ayikho zihlelwa myopathy okubangelwa ngokusebenzisa "Losartan". Oku nje ngokubange- jikelele, nto leyo nayo kuvandlakanywa qembu. Ichiza kakuhle ngokwenene kunyanyezelwa lula kakhulu kunokuba "Lorista H" yaye "Lorista" ND "ekubeni iziphumo zabo ebezingalindelekanga ziquka ezo iimeko zibangelwa ngaphezu hydrochlorothiazide. Ngaphandle koku, zontathu iinketho "Loristy 'ekhuselekileyo ezibalulekileyo practice ngamayeza nokunyanga.

Izimo

Zonke analogue "Loristy" yaye "Cozaar 'kuquka" Lozap "umyalelo (ixabiso elikhankanywe ngezantsi) uyakuthintela ukusetyenziswa kwezi meko zilandelayo:

• kuphuhliso lwesicwangciso uxabane nawo nawuphi na amalungiselelo eziqulathe "Losartan";

• abantwana abangaphantsi kweminyaka eli-18 ubudala ngenxa yokuba izibonelelo bokuba kunye neziphumo ebezingalindelekanga ayaziwa kwezi zigulane;

• ngethuba lokukhulelwa zisanyisa.

Izigulane izilonda sezintso iziyobisi ezikhoyo "Lorista" kanga, njengokuba iphucula ukuhamba kwegazi kwezintso kwaye iguqulela ukusebenza nephroprotective. Kwakhona, "Losartan" na eliqhelekileyo, kodwa isiphumo eyingenelo, oko ibalekisa kukhuthaza uric acid, kunokuba isantya uphuhliso exacerbations of sifo. Noko ke, oko isetyenziswa ngobunono ukusilela esibindini. Le meko lwezonyango kugqalwa contraindication isalamane.

iimpawu reception

Ichiza "Lorista", "Lozap", "Bloktran ',' Cozaar ',' Vazotenz" ixabiso yahlukile, kodwa iimpawu ezifanayo yesicelo. Ngokukodwa, ichiza ethathwa kanye kwi iqondo ezilungileyo kolawulo uxinzelelo lwegazi okanye kwindawo ephantsi ekwandiseni ngayo. Ukuba lwegazi sinobuzaza, kunye ekhwela rhoqo, nto ifuna ukusetyenziswa "Losartan" kabini. Kunqweneleka ukuba kusoloko ukusebenzisa amachiza ngexesha elinye, nto leyo kuphucula izinga lolawulo xi noqikelelo ke sifo.

Drug "Lorista" ingasiwa ngaphandle ngokuphathelele ukutya, ukusela umlinganiselo onguwo amanzi. Kwisabelo ephambili umfutho wayo uvela ngokuthe ngcembe yaye ifikelela incopho kwiiveki nje emva 1-2. Kule "Losartan" kunye nabanye (ARBs) blocker angiotensin receptor obuphantsi kakhulu ukuba Ace inhibitor. Noko ke, ARBs kufuneka inkalo kubalulekile - ayinayo iziphumo ebezingalindelekanga ezifana ukhohlokhohlo owomileyo ngenxa beqokelela bradykinin. ARBs nabo esibonakala ngokungabikho isiphumo amanyathelo umfutho yokusinda, nto leyo uphawu ukusetyenziswa kwexesha elide ACE inhibitor.

kunikezelo

"Lorista" ifumaneka emacwecweni, kunye iqokobhe nzima. Iidosi zigqitywa mass "Losartan" umnikelo tablet enye. Kukho iindlela ezintathu "Loristy" amathamo ka-12.5, 25, 100 mg. Kwakhona ndaqonda nokulungiswa edibeneyo phantsi kwalo tradename uquka izinto ezimbini esebenzayo "Losartan" yaye "Hydrochlorothiazide", nto leyo kudityaniswe omnye komnye. Ukuba ziyafumaneka iidosi zilandelayo:

• 100 mg of losartan + 12.5 mg hydrochlorothiazide - ukulungiselela "Lorista H100";

• 50 mg of losartan 12.5 mg hydrochlorothiazide + - iziyobisi "Lorista H";

• 100 mg of losartan + 25 mg hydrochlorothiazide - ukulungiselela "Lorista ND".

Emacwecweni, kunye idosi efanayo zentengiso kunye naluphi analogue "Loristy" esiza network ekhemesti.

"Loristy» Price

Ixabiso "Lorista" iziyobisi yahluka kwezinye iingingqi zeli lizwe. Oku kuxhomekeka kwiimpawu yonikezelo kunye nokufikelela ukuphunyezwa. Iyeza usoloko zitshiphu besemizini yabo, apho kukho amaziko iimvavanyo ubuchule kunye neziyobisi. Ukusukela nganye ngeemveliso zamachiza, kungakhathaliseki nokuba ngaba amazwe okanye abethwe ekhayeni lakhe, kufuneka uphumelele uvavanyo sigaba iqela, yinto yokwemvelo kweli lizwe kutshiphu kwikomkhulu. E Moscow, 30 amacwecwe ixabiso ichiza "Lorista" imi ngolu hlobo lulandelayo:

• "Lorista 12.5 mg" ezixabisa 100-150 engange;

• "Lorista 25 mg" ixabiso engange 160-210;

• "Lorista 50 mg" ixabiso engange 180-270;

• "Lorista 100 mg" - 270-330 engange;

• "Lorista H" (50 mg) - 250-300 engange.

Ukulungiselela "Lorista" ingcinezelo Igcwele 30, 60 okanye 90 iipilisi. Abaguli inceda ichiza ngempumelelo ukulawula lwegazi, kunokwenzeka ukuba abe iphakheji enkulu. Oku kuluncedo ngokwezoqoqosho, ngokuba ezi phakheji ezintathu iipilisi 30 wesithathu ngaphezu kwesinye pack iipilisi 90.

nucleoside cheap "Loristy"

Le nkampani KRKA ohlonelwa nkonzo, kuba amachiza eziveliswa ngayo ukuhlangabezana neemfuno lwezonyango. Kodwa ke, umgangatho wabo lubonakala izifundo bioequivalence kwi "losartan" original - "Cozaar". Nangona kunjalo, kukho ezinye izinto eziqulathe "Losartan". Xa Elungiselela "Lorista" analogue nawethutyana, kusenokuba zitshiphu. Xa Imizekelo "Vazotenz", "Bloktran", "Prezartan".

Togu le ibiza - "Bloktran", nto leyo enika kubunzima lefom umthamo le, kodwa a ngempumelelo efanayo njenge "Lorista". "Vazotenz" kancinane ibiza ngaphezu "Bloktran", nangona phantse ukusebenza efanayo. Le kukhethwa kule meko nokufikeleleka. Ngelo xesha elinye ichiza "Bloktran" Ufundo twatse naleyo naziphi analogue eziqulathe "Losartan". Oku wemvelo.

nabalingani Commercial "Loristy"

Kukho iziyobisi ezininzi eziqulathe "Losartan" njengoko into esebenzayo. Bona babe amanani ezahlukeneyo kunye nomgangatho. Kulo mzekelo, nayiphi na analog na "Loristy" kodwa ichiza 'Cozaar' yileyo ifanayo. "Lorista" - kwakhona ikopi mvume ye-"Losartan" original - ichiza 'Cozaar'. Ngoko ke, ukulinganisa, isiseko nexabiso kunye nokusebenza esisiso uwuthathe ichiza, eziveliswa inkampani Swiss Merck eSHARP & DOHME IDEA, Inc. original Phakathi noogxa commercial "Loristy" iziyobisi ezikhoyo iindidi ezintathu ixabiso:

• ixabiso eliphezulu ( "Cozaar" "Amzaar" "Gizaar");

• ne malunga ngexabiso elifanayo ( "Losartan-Teva", "Losap" "Lorista" "Centaur");

• amachiza zitshiphu ( "Losartan NAS," "Losartan-Richter," "Losartan Belmedpreparaty", "Prezartan", "Bloktran", "Vazotenz").

Ixabiso amalungiselelo isigaba sokuqala Ibanga engange 500-1000 ngenxa ekupakisheni iipilisi ezinomthamo ka 30 "Losartan" 100 no-50 mg. amalungiselelo kolimo eziquka 25 okanye 12.5 mg "hydrochlorothiazide" kunye ne-100 okanye 50 mg "Losartan", ngokulandelelana, ngaba engange malunga 800-1000 tablet-30.

Amalungiselelo yee-ngexabiso kalukhuni bahambelana ixabiso "Loriste". Nayiphi analogs ezinjalo "Loristy" abonela uluhlu ixabiso ka 300-600 engange, ngokuxhomekeke idosi yokudibanisa with "hydrochlorothiazide". A iimveliso ephantsi amaxabiso ulingana ukuya ku-300 - 400 engange, ezo ezifunekayo ukuze ikhosi ngenyanga kunyango.

Eyona ingabizi kakhulu sesona siyobisi "Lorista", "Centaur", "Lozap" "Losartan National Academy of Sciences." Phakathi ezizezinye ezikhoyo ngexabiso leyo amayeza ngcono. owuthandayo kwiimeko zithile phakathi nayiphi "Losartan" esukela - ukulungiselela "Cozaar," yona yokuqala. Nokusebenzisa kwayo ngempumelelo eqinisekisiwe, "Losartan" bengabameli umfutho.

iingcali Izimvo

Iingcali abasakwazi kakuhle ichiza "Lorista", ngenxa yokuba ukusebenza kwayo kufunyaniswe kuphononongo bioequivalence 'Cozaar'. Kaloku Kuthathwa ngokuba "Lorista" - ayibizi 'Cozaar' yokuqala. ingxelo entle evela kwiingcali zaye kufaneleyo ngenxa yokungabikho ukusebenza yesenzo umfutho yokusinda. Noko ke, ichiza, kukho iingxaki xa kwiklasi ye blocker receptor angiotensin. isiphumo yabo kade, nto leyo ethintela ukuba uqhubeke ngoko nangoko unyango lwe lwegazi okanye amagunya eliphezulu ukusebenzisa amayeza xa zibeyintlekele.

baqinisekiswa

Xa yokwamkelwa kwabafundi rhoqo, izigulane ingxelo inani elincinane ziziphumo ebezingalindelekanga, musa ziyahluka ukusuka manani exelwe imiyalelo apha. Ichiza kakuhle kwaye ngokufanayo ukulawula uxinzelelo lwegazi, ngenxa leyo kunciphisa kakhulu amathuba iingxaki. Kwakhona, izigulane inkunzi ingxelo ukuba "Lorista" ayithethi ukunciphisa amandla, njengoko kunjalo nge-ACE inhibitors. Ngokubanzi, "Lorista" iphawulwa njengendlela ethembekileyo ekhuselekileyo unyango wegazi.